Overview
- 38 inspections across 36 sites are on record.
- 147 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-06-03.
At a glance
Inspections
38
Sites
36
Observations
147
Career since
Aug 2022
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Eurofins SF Analytical Laboratories, Inc. | 3 Jun 2026 | Human Drugs | View 483 → |
| Mylan Pharmaceuticals Inc | 28 Apr 2026 | Human Drugs | |
| ChemPacific Corporation | 7 Apr 2026 | Human Drugs | On file |
| Pharmaceutics International, Inc. | 6 Mar 2026 | Human Drugs | View 483 → |
| MSD International GmbH (Singapore Branch) | 23 Jan 2026 | Human Drugs | On file |
Sites inspected
Eurofins SF Analytical Laboratories, Inc.Horsham, United States1 insp.
Mylan Pharmaceuticals IncMorgantown, United States1 insp.
ChemPacific CorporationBaltimore, United States1 insp.
Pharmaceutics International, Inc.Cockeysville, United States1 insp.
MSD International GmbH (Singapore Branch)Singapore, Singapore1 insp.
Co-investigators
Investigators who share inspections with this person.
Michael O Idowu5 shared
Catherine O Lamptey5 shared
Olumide A Akinyemi4 shared
Yaharn Su3 shared
Tanya R Syffrard2 shared
Claude Noel Y Zanetsie2 shared
Azeezat M Lawal2 shared
Paige R Mccoy2 shared
Khalid M Khan2 shared
Marcellinus D Dordunoo2 shared
Full investigator report
Get the verbatim findings behind Pushpa S Jayasekara's 147 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site